Search J Rheum

Advanced Search

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

Decreased Expression of Proliferating Cell Nuclear Antigen Is Associated with Dexamethasone Inhibition of the Proliferation of Rat Tendon Fibroblasts

WEN-CHUNG TSAI, FUK-TAN TANG, MAY-KUEN WONG, HSIAO-CHENG YEN, and JONG-HWEI S. PANG

ABSTRACT.

Objective. To investigate the effects of dexamethasone (Dex) on the proliferation of cultured rat Achilles tendon fibroblasts at concentrations typically used for local injection treatment.

Methods. Fibroblasts cultured from rat Achilles tendons were treated with Dex at concentrations of 0, 10-4, 3 ´ 10-4, and 10-3 M. [3H]thymidine incorporation was used to measure the rate of cell proliferation. mRNA expression of proliferating cell nuclear antigen (PCNA) and cyclin kinase inhibitor p21CIP1 was determined by reverse transcription-polymerase chain reaction (RT-PCR). The protein levels of PCNA and p21CIP1 were investigated by Western blot analysis.

Results. An initial inhibitory effect on tendon fibroblast proliferation was observed at a concentration of 10-4 M. Further, a significant decline in [3H]thymidine incorporation as a function of Dex concentration was noted (p = 0.019). RT-PCR results revealed that PCNA mRNA expression was inhibited after Dex treatment. Western blot analysis of PCNA protein also revealed Dex downregulation. Gradual declines in the levels of PCNA mRNA expression and PCNA protein as a function of Dex concentration were noted. The expression of p21CIP1 both at mRNA and the protein levels remained constant.

Conclusion. These results suggest that Dex inhibition of the proliferation of rat tendon fibroblasts is associated with a p21CIP1 independent decrease of the PCNA gene expression. (J Rheumatol 2002;29:2397-402)

Key Index Terms:

DEXAMETHASONE
TENDON
FIBROBLAST
PROLIFERATING CELL NUCLEAR ANTIGEN


From the Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital and the Graduate Institute of Clinical Medical Sciences, Chang Gung University, Gueishan, Taoyuan, Taiwan.

W-C. Tsai, MD; F-T. Tang, MD, Associate Professor and Department Head, Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital; M-K. Wong, MD, Professor and Vice Superintendent, Chang Gung Memorial Hospital; H-C. Yen, MS, Teaching Assistant; J-H.S. Pang, PhD, Associate Professor, Chang Gung University.

Address reprint requests to Dr. J-H.S. Pang, Graduate Institute of Clinical Medical Sciences, Chang Gung Memorial Hospital, 5, Fu-Shin Street, Gueishan, Taoyuan, Taiwan. E-mail: jonghwei@mail.cgu.edu.tw

Submitted September 21, 2001; revision accepted May 10, 2002.




Return to November 2002 Table of Contents



© 2002. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.